Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

331 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Intensive chemotherapy with autologous stem cell transplantation in ovarian cancers: analysis of 67 patients treated at the Paoli-Calmettes Institute and a review of the literature].
Viens P, Bertucci F, Gravis G, Camerlo J, Cowen D, Delpero JR, Conte M, Jacquemier J, Faucher C, Blaise D, Bardou VJ, Chabannon C, Blanc AP, Jaubert D, Maraninchi D. Viens P, et al. Among authors: jacquemier j. Bull Cancer. 1997 Sep;84(9):869-76. Bull Cancer. 1997. PMID: 9435808 Review. French.
Association of angiogenesis and poor prognosis in node-positive patients receiving anthracycline-based adjuvant chemotherapy.
Viens P, Jacquemier J, Bardou VJ, Bertucci F, Penault-Llorca F, Puig B, Gravis G, Oziel-Taïeb S, Resbeut M, Houvenaeghel G, Camerlo J, Birbaum D, Hassoun J, Maraninchi D. Viens P, et al. Among authors: jacquemier j. Breast Cancer Res Treat. 1999 Apr;54(3):205-12. doi: 10.1023/a:1006112927565. Breast Cancer Res Treat. 1999. PMID: 10445419
First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 trial).
Viens P, Palangié T, Janvier M, Fabbro M, Roché H, Delozier T, Labat JP, Linassier C, Audhuy B, Feuilhade F, Costa B, Delva R, Cure H, Rousseau F, Guillot A, Mousseau M, Ferrero JM, Bardou VJ, Jacquemier J, Pouillart P. Viens P, et al. Among authors: jacquemier j. Br J Cancer. 1999 Oct;81(3):449-56. doi: 10.1038/sj.bjc.6690714. Br J Cancer. 1999. PMID: 10507769 Free PMC article. Clinical Trial.
Overexpression of erb B2 remains a major risk factor in non-metastatic breast cancers treated with high-dose alkylating agents and autologous stem cell transplantation.
Braud AC, Mathoulin Portier MP, Bardou VJ, Bertucci F, Gravis G, Camerlo J, Begue M, Houvenaeghel G, Maraninchi D, Jacquemier J, Viens P. Braud AC, et al. Among authors: jacquemier j. Bone Marrow Transplant. 2002 May;29(9):753-7. doi: 10.1038/sj.bmt.1703540. Bone Marrow Transplant. 2002. PMID: 12040472
Multivariate analysis of survival in inflammatory breast cancer: impact of intensity of chemotherapy in multimodality treatment.
Bertucci F, Tarpin C, Charafe-Jauffret E, Bardou VJ, Braud AC, Tallet A, Gravis G, Viret F, Gonçalves A, Houvenaeghel G, Blaise D, Jacquemier J, Maraninchi D, Viens P. Bertucci F, et al. Among authors: jacquemier j. Bone Marrow Transplant. 2004 May;33(9):913-20. doi: 10.1038/sj.bmt.1704458. Bone Marrow Transplant. 2004. PMID: 15004544
331 results